Kushal Vyas, ELC Group, looks at barriers to generic entry in Europe
Access to medicine and return on investment have always been key public policy considerations for governments to balance increasing healthcare cost and promote innovation.
Medicine in Europe: what are the barriers?
Kushal Vyas, ELC Group, looks at barriers to generic entry in Europe
Published:
|
3 min read
Last updated:
Sign up to our newsletter
The week's biggest stories from this industry, direct to your inbox.